Skip to content

Evaluation of Physical Exercise to Prevent Functional Deterioration During Hospitalization (EFFAPRO)

Evaluation of Physical Exercise as a Protective Factor for the Loss of Functional Capacity in Patients With Metastatic Tumors During Hospitalization. Pilot Study (EFFAPRO)

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05281250
Acronym
EFFAPRO
Enrollment
0
Registered
2022-03-16
Start date
2018-08-28
Completion date
2018-08-28
Last updated
2022-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Patients, Hospitalized

Keywords

rehabilitation, physical activity, Physical condition

Brief summary

This is a randomized study that will measure the possible benefit of supervised training during the hospitalization of patients with stage IV neoplasms in active treatment.

Detailed description

The trial is not going to be runned

Interventions

A supervised exercise is randomized. Although this intervention is not standard in our setting, it is a recommended practice, since it is known that rehabilitation strategies in hospitalized patients have different benefits.

Sponsors

Puerta de Hierro University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with stage IV neoplasms. * Active treatment: chemotherapy, hormone therapy, immunotherapy or targeted therapies. * Hospitalization at Medical Oncology Departmentof the Hospital Puerta de Hierro. * Reason for hospitalization is expected to be solved in less than two weeks.

Exclusion criteria

* Patients who do not wish to participate. * Cognitive impairment. * Hospitalization due to progression of oncological disease. * Acute coronary syndrome or bone fracture in limbs during the previous three months.

Design outcomes

Primary

MeasureTime frameDescription
Functional capacityThrough study completion (average 10 days)Functional Independence Measure (FIM)

Secondary

MeasureTime frameDescription
Cardiorespiratory conditionThrough study completion (average 10 days)Six minute test .
Daily physical activityThrough study completion (average 10 days)Accelerometry during the hospitalization.
Fatigue-FACITThrough study completion (average 10 days)FACIT Fatigue Scale
StrengthThrough study completion (average 10 days).Dynamometry
Life quality: Q30 questionnaireThrough study completion (average 10 days)QLQ30 questionnaire (quality of life). 0-100 (HIGHER, better)
Anxiety and depressionThrough study completion (average 10 days)HADS questionnaire (anxiety and depression). 0-42 (less better)
Length of hospital stayThrough study completion (average 10 days).Number of days the patient is hospitalized.
Fatigue-PERFORMThrough study completion (average 10 days)PERFORM Fatigue questionnaire (12-60) Higher, better (less fatigue)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026